Home/Filings/4/0001209191-22-053579
4//SEC Filing

Fairman Jeff 4

Accession 0001209191-22-053579

CIK 0001649094other

Filed

Oct 12, 8:00 PM ET

Accepted

Oct 13, 4:57 PM ET

Size

6.2 KB

Accession

0001209191-22-053579

Insider Transaction Report

Form 4
Period: 2022-10-11
Fairman Jeff
VP, Research
Transactions
  • Sale

    Common Stock

    2022-10-11$25.50/sh5,000$127,500296,227 total(indirect: By Trust)
Holdings
  • Common Stock

    17,143
  • Common Stock

    (indirect: By Trust)
    50,000
Footnotes (1)
  • [F1]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.

Issuer

Vaxcyte, Inc.

CIK 0001649094

Entity typeother

Related Parties

1
  • filerCIK 0001813800

Filing Metadata

Form type
4
Filed
Oct 12, 8:00 PM ET
Accepted
Oct 13, 4:57 PM ET
Size
6.2 KB